Product Information

BRINZOLAMIDE 1% EYE DROPS is a generic product labeled by Padagis US LLC, priced at $9.4893 per ML under NDC 00574401210. Its NADAC has been published 141 times since Dec 13, 2023.

FDA first approved this application on Jul 28, 2023.

BRINZOLAMIDE 1% EYE DROPS

brinzolamide
$9.4893per ML

Strength

10 mg/mL

Manufacturer

Padagis US LLC

NDC

00574401210

Classification

Generic

Dosage Form

SUSPENSION/ DROPS

Route

OPHTHALMIC

Effective Date

8/19/2026

Active Ingredients

BRINZOLAMIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA211914

FDA Approved

7/28/2023

On Market Since

10/10/2023

Pharmacological Classes

Carbonic Anhydrase Inhibitor
Carbonic Anhydrase Inhibitors

Price Statistics

The NADAC for BRINZOLAMIDE 1% EYE DROPS has been published 141 times since Dec 13, 2023, and over the history we have for it it has declined 39.7%. The table below summarizes its recorded NADAC range and movement.

Current price$9.4893 per ML
All-time high$15.7293 (Dec 13, 2023)
All-time low$9.4893 (Aug 19, 2026)
52-week high$12.9336
52-week low$9.4893
Median price$12.2477
Average price$12.3776
Largest weekly change+26.9% (Aug 21, 2024)
Weeks tracked141
Tracking sinceDec 13, 2023

Price History

1W

-2.9%

1M

-2.9%

3M

-6.1%

6M

-8.8%

1Y

-15.1%

3Y

N/A

5Y

N/A

All

-39.7%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of BRINZOLAMIDE 1% EYE DROPS?

The current National Average Drug Acquisition Cost (NADAC) for BRINZOLAMIDE 1% EYE DROPS, manufactured by Padagis US LLC, is $9.4893 per ML (NDC 00574401210), effective Aug 19, 2026.

How has the price of BRINZOLAMIDE 1% EYE DROPS changed over time?

Over the history we have for it, the NADAC for BRINZOLAMIDE 1% EYE DROPS has declined 39.7%. It has been tracked across 141 weekly CMS publications since Dec 13, 2023.

What are the highest and lowest recorded NADAC prices for BRINZOLAMIDE 1% EYE DROPS?

Since Dec 13, 2023, the NADAC for BRINZOLAMIDE 1% EYE DROPS has ranged from a low of $9.4893 (Aug 19, 2026) to a high of $15.7293 (Dec 13, 2023), with a median of $12.2477 per ML.

Are there cheaper alternatives to BRINZOLAMIDE 1% EYE DROPS?

5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BRINZOLAMIDE 1% EYE DROPS in a comparable dosage form, but none are currently priced below it.

Who manufactures BRINZOLAMIDE 1% EYE DROPS?

BRINZOLAMIDE 1% EYE DROPS (NDC 00574401210) is labeled by Padagis US LLC, and CMS classifies it as a generic product.